Actively Recruiting
Application of CfDNA Methylation Detection in Auxiliary Diagnosis of Breast Cancer
Led by Geneplus-Beijing Co. Ltd. · Updated on 2025-03-14
200
Participants Needed
1
Research Sites
76 weeks
Total Duration
On this page
Sponsors
G
Geneplus-Beijing Co. Ltd.
Lead Sponsor
C
Chinese Academy of Medical Sciences
Collaborating Sponsor
AI-Summary
What this Trial Is About
The purpose of this study is to construct an auxiliary diagnostic model for breast cancer by methylation markers. The study will collect blood and tissue samples from participants with breast cancer and benign disease for whole-genome methylation sequencing. It will screen methylation markers and develop a methylation auxiliary diagnosis model to distinguish between breast cancer and non-cancer.
CONDITIONS
Official Title
Application of CfDNA Methylation Detection in Auxiliary Diagnosis of Breast Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Confirmed pathological diagnosis and molecular subtyping results
- Ability to provide written informed consent
You will not qualify if you...
- History of or currently suffering from other malignancies (cancer arm)
- Pregnant or planning to become pregnant (cancer arm)
- Received cancer treatment before blood draw, including surgery, chemotherapy, radiotherapy, targeted therapy, or immunotherapy (cancer arm)
- History of blood transfusion within the past month (cancer arm)
- History of allogeneic organ transplantation or hematopoietic stem cell transplantation (cancer arm)
- Persistent fever or undergoing anti-inflammatory treatment within 14 days before blood draw (cancer arm)
- Any condition that may make participation unsuitable or interfere with study completion (cancer arm)
- Poor physical condition not suitable for blood draw (cancer arm)
- Unable or unwilling to provide informed consent or blood sample (cancer arm)
- History of malignancies (benign diseases arm)
- Current malignancies or precancerous lesions (benign diseases arm)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Beijing, Beijing Municipality, China, 100021
Actively Recruiting
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here